Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2

Oncogene

Volumn 32, Issue 37, 2013, Pages 4355-4365

  Porsch, H ^a   Bernert, B ^a   Mehic M ^a   Theocharis, A D ^a,b   Heldin, C H ^a   Heldin, P ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

EMT; Growth factors; Hyaluronan synthase 2; Migration; TGFb

Indexed keywords

CELL SURFACE RECEPTOR; FIBRONECTIN; HERMES ANTIGEN; HYALURONAN SYNTHASE 2; HYALURONIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD44; CELL MOVEMENT; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; MAMMARY GLANDS, HUMAN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

STREPTOMYCES;

EID: 84884208384     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.475     Document Type: Article

References (55)

1. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
2. Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98: 1512-1520.
3. Toole BP. Hyaluronan in morphogenesis. Semin Cell Dev Biol 2001; 12: 79-87.
4. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397-2404.
5. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-539.
6. Watanabe K, Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase. J Biol Chem 1996; 271: 22945-22948.
7. Itano N, Kimata K. Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J Biol Chem 1996; 271: 9875-9878.
8. Shyjan AM, Heldin P, Butcher EC, Yoshino T, Briskin MJ. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem 1996; 271: 23395-23399.
9. Spicer AP, Olson JS, McDonald JA. Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem 1997; 272: 8957-8961.
10. Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 1998; 273: 1923-1932.
11. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085-25092.
12. Brinck J, Heldin P. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res 1999; 252: 342-351.
13. Toole BP, Slomiany MG. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 2008; 18: 244-250.
14. Anttila MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000; 60: 150-155.
15. Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000; 156: 529-536.
16. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro Jr A et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000; 106: 349-360.
17. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002; 8: 850-855.
18. Zoltan-Jones A, Huang L, Ghatak S, Toole BP. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 2003; 278: 45801-45810.
19. Li Y, Heldin P. Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 2001; 85: 600-607.
20. Massague J. TGFbeta in Cancer. Cell 2008; 134: 215-230.
21. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009; 136: 3699-3714.
22. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N et al. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 2008; 10: 1199-1207.
23. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 2008; 31: 918-924.
24. Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymovych M et al. TRAF6 ubiquitinates TGFbeta type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2011; 2: 330.
25. Heldin P, Laurent TC, Heldin C-H. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 1989; 258: 919-922.
26. Li Y, Rahmanian M, Widstrom C, Lepperdinger G, Frost GI, Heldin P. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am J Respir Cell Mol Biol 2000; 23: 411-418.
27. Usui T, Amano S, Oshika T, Suzuki K, Miyata K, Araie M et al. Expression regulation of hyaluronan synthase in corneal endothelial cells. Invest Ophthalmol Vis Sci 2000; 41: 3261-3267.
28. Jacobson A, Brinck J, Briskin MJ, Spicer AP, Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J 2000; 348(Pt 1): 29-35.
29. Li L, Asteriou T, Bernert B, Heldin CH, Heldin P. Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J 2007; 404: 327-336.
30. Stuhlmeier KM, Pollaschek C. Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation. J Biol Chem 2004; 279: 8753-8760.
31. Meran S, Thomas D, Stephens P, Martin J, Bowen T, Phillips A et al. Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem 2007; 282: 25687-25697.
32. Simpson RM, Wells A, Thomas D, Stephens P, Steadman R, Phillips A. Aging fibroblasts resist phenotypic maturation because of impaired hyaluronandependent CD44/epidermal growth factor receptor signaling. Am J Pathol 2010; 176: 1215-1228.
33. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12: 27-36.
34. Gal A, Sjoblom T, Fedorova L, Imreh S, Beug H, Moustakas A. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 2008; 27: 1218-1230.
35. Sato N, Maehara N, Goggins M. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res 2004; 64: 6950-6956.
36. Unger K, Wienberg J, Riches A, Hieber L, Walch A, Brown A et al. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr Relat Cancer 2010; 17: 87-98.
37. Bernert B, Porsch H, Heldin P. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). J Biol Chem 2011; 286: 42349-42359.
38. Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S et al. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res 2011; 72: 537-547.
39. Olsson M, Meadows JR, Truve K, Rosengren Pielberg G, Puppo F, Mauceli E et al. A novel unstable duplication upstream of HAS2 predisposes to a breed-defining skin phenotype and a periodic fever syndrome in Chinese Shar-Pei dogs. PLoS Genet 2011; 7: e1001332.
40. Bakkers J, Kramer C, Pothof J, Quaedvlieg NEM, Spaink HP, Hammerschmidt M. Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation. Development 2004; 131: 525-537.
41. Takahashi E, Nagano O, Ishimoto T, Yae T, Suzuki Y, Shinoda T et al. Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem 2010; 285: 4060-4073.
42. Wang A, de la Motte C, Lauer M, Hascall V. Hyaluronan matrices in pathobiological processes. FEBS J 2011; 278: 1412-1418.
43. Karousou E, Kamiryo M, Skandalis SS, Ruusala A, Asteriou T, Passi A et al. The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem 2010; 285: 23647-23654.
44. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003; 112: 1116-1124.
45. Wakefield LM, Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002; 12: 22-29.
46. Boregowda RK, Appaiah HN, Siddaiah M, Kumarswamy SB, Sunila S, Thimmaiah KN et al. Expression of hyaluronan in human tumor progression. J Carcinog 2006; 5: 2.
47. Evanko SP, Wight T. Intracellular hyaluronan. http://wwwglycoforumgrjp/ science/hyaluronan/HA20/HA20Ehtml 2001.
48. Evanko SP, Parks WT, Wight TN. Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle. J Histochem Cytochem 2004; 52: 1525-1535.
49. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA et al. Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 2004; 1673: 3-12.
50. Li Y, Li L, Brown TJ, Heldin P. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 2007; 120: 2557-2567.
51. Heldin P, de la Torre M, Ytterberg D, Bergh J. Differential synthesis and binding of hyaluronan by human breast cancer cell lines: relationship to hormone receptor status. Oncology Rep 1996; 3: 1011-1016.
52. Takebe N, Warren RQ, Ivy SP. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-tomesenchymal transition. Breast Cancer Res 2011; 13: 211.
53. Williams CM, Engler AJ, Slone RD, Galante LL, Schwarzbauer JE. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res 2008; 68: 3185-3192.
54. Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA et al. Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J Biol Chem 2010; 285: 409-421.
55. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004; 24: 4241-4254.